A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice

Human Molecular Genetics

Volumn 17, Issue 9, 2008, Pages 1201-1213

  Kobuke, Kazuhiro ^a   Piccolo, Federica ^a   Garringer, Keith W ^a   Moore, Steven A ^a   Sweezer, Eileen ^a   Yang, Baoli ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SARCOGLYCAN; GLYCOPROTEIN; MUTANT PROTEIN; NEOMYCIN; SARCOGLYCAN; SARCOSPAN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CREATINE KINASE; MEMBRANE PROTEIN; SSPN PROTEIN, MOUSE; TUMOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DISEASE MODEL; GENE DELETION; GENE LOCUS; HOMOZYGOTE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2D; MISSENSE MUTATION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TRANSPORT; SARCOLEMMA; SKELETAL MUSCLE; SPECIES DIFFERENCE; ADENOVIRUS; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BLOOD; C57BL MOUSE; GENETICS; METABOLISM; MOUSE MUTANT; TRANSGENIC MOUSE;

MUS;

ADENOVIRIDAE; ANIMALS; CARRIER PROTEINS; CREATINE KINASE; DISEASE MODELS, ANIMAL; HOMOZYGOTE; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, STRIATED; MUSCULAR DYSTROPHY, ANIMAL; MUTATION, MISSENSE; NEOPLASM PROTEINS; SARCOGLYCANS; SARCOLEMMA;

EID: 42449134946     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn009     Document Type: Article

References (58)

1. Gardner-Medwin, D. and Walton, J.N. (1994) The muscular dystrophies. In Walton, J.N., Karpati, G. and Hilton-Jones, D. (eds), Disorders of Voluntary Muscle, 6th edn. Churchill Livingstone, New York, NY, pp. 543-594.
2. Walton, J.N. and Nattrass, F.J. (1954) On the classification, natural history and treatment of the myopathies. Brain, 77, 169-231.
3. Bushby, K.M. (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul. Disord., 5, 71-74.
4. Durbeej, M. and Campbell, K.P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models. Curr. Opin. Genet. Dev., 12, 349-361.
5. Moore, S.A., Shilling, C.J., Westra, S., Wall, C., Wicklund, M.P., Stolle, C., Brown, C.A., Michele, D.E., Piccolo, F., Winder, T.L. et al. (2006) Limb-girdle muscular dystrophy in the United States. J. Neuropathol. Exp. Neurol., 65, 995-1003.
6. Moreira, E.S., Vainzof, M., Suzuki, O.T., Pavanello, R.C., Zatz, M. and Passos-Bueno, M.R. (2003) Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations. J. Med. Genet., 40, E12.
7. Fanin, M., Duggan, D.J., Mostacciuolo, M.L., Martinello, F., Freda, M.P., Soraru, G., Trevisan, C.P., Hoffman, E.P. and Angelini, C. (1997) Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J. Med. Genet., 34, 973-977.
8. Duggan, D.J., Manchester, D., Stears, K.P., Mathews, D.J., Hart, C. and Hoffman, E.P. (1997) Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics, 1, 49-58.
9. Piccolo, F., Roberds, S.L., Jeanpierre, M., Leturcq, F., Azibi, K., Beldjord, C., Carrie, A., Recan, D., Chaouch, M., Reghis, A. et al. (1995) Primary adhalinopathy: A common cause of autosomal recessive muscular dystrophy of variable severity. Nat. Genet., 10, 243-245.
10. Eymard, B., Romero, N.B., Leturcq, F., Piccolo, F., Carrie, A., Jeanpierre, M., Collin, H., Deburgrave, N., Azibi, K., Chaouch, M. et al. (1997) Primary adhalinopathy (alpha-sarcoglycopathy): Clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology, 48, 1227-1234.
11. Carrie, A., Piccolo, F., Leturcq, F., de Toma, C., Azibi, K., Beldjord, C., Vallat, J.M., Merlini, L., Voit, T., Sewry, C. et al. (1997) Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J. Med. Genet., 34, 470-475.
12. Ervasti, J.M. and Campbell, K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol., 122, 809-823.
13. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and Sweeney, H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA, 90, 3710-3714.
14. Weller, B., Karpati, G. and Carpenter, S. (1990) Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci., 100, 9-13.
15. Duclos, F., Straub, V., Moore, S.A., Venke, D.P., Hrstka, R.F., Crosbie, R.H., Durbeej, M., Lebakken, C.S., Ettinger, A.J.; van der Meulen, J. et al. (1998) Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J. Cell Biol., 142, 1461-1471.
16. Durbeej, M., Cohn, R.D., Hrstka, R.F., Moore, S,A., Allamand, V., Davidson, B.L., Williamson, R.A. and Campbell, K.P. (2000) Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol. Cell, 5, 141-151.
17. Araishi, K., Sasaoka, T., Imamura, M., Noguchi, S., Hama, H., Wakabayashi, E., Yoshida, M., Hori, T. and Ozawa, E. (1999) Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum. Mol. Genet., 8, 1589-1598.
18. Iwata, Y., Nakamura, H., Mizuno, Y., Yoshida, M., Ozawa, E. and Shigekawa, M. (1993) Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart. FEBS Lett., 329, 227-231.
19. Roberds, S.L., Ervasti, J.M., Anderson, R.D., Ohlendieck, K., Kahl, S.D., Zoloto, D. and Campbell, K.P. (1993) Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J. Biol. Chem., 268, 11496-11499.
20. Rando, T.A. (2001) The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve, 24, 1575-1594.
21. Holt, K.H. and Campbell, K.P. (1998) Assembly of the sarcoglycan complex. Insights for muscular dystrophy. J. Biol. Chem., 273 34667-34670.
22. Crosbie, R.H., Lim, L.E., Moore, S.A., Hirano, M., Hays, A.P., Maybaum, S.W., Collin, H., Dovico, S.A., Stolle, C.A., Fardeau, M. et al. (2000) Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan interactions. Hum. Mol. Genet., 9 2019-2027.
23. Lebakken, C.S., Venzke, D.P., Hrstka, R.F., Consolino, C.M., Faulkner, J.A., Williamson, R.A. and Campbell, K.P. (2000) Sarcospan-deficient mice maintain normal muscle function. Mol. Cell. Biol., 20, 1669-1677.
24. Hack, A.A., Ly, C.T., Jiang, F., Clendenin, C.J., Sigrist, K.S., Wollmann, R.L. and McNally, E.M. (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell Biol., 142, 1279-1287.
25. Sasaoka, T., Imamura, M., Araishi, K., Noguchi, S., Mizuno, Y., Takagoshi, N., Hama, H., Wakabayashi-Takai, E., Yoshimoto-Matsuda, Y., Nonaka, I. et al. (2003) Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice. Neuromuscul. Disord., 13, 193-206.
26. Coral-Vazquez, R., Cohn, R.D., Moore, S.A., Hill, J.A., Weiss, R.M., Davisson, R.L., Straub, V., Barresi, R., Bansal, D., Hrstka, R.F. et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy. Cell, 98, 465-474.
27. Hack, A.A., Lam, M.Y., Cordier, L., Shoturma, D.I., Ly, C.T, Hadhazy, M.A., Hadhazy, M.R., Sweeney, H.L. and McNally, E.M. (2000) Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J. Cell Sci., 113, 2535-2544.
28. Lakso, M., Pichel, J.G., Gorman, J.R., Sauer, B., Okamoto, Y., Lee, E., Alt, F.W. and Westphal, H. (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA, 93, 5860-5865.
29. O'Gorman, S., Dagenais, N.A., Qian, M. and Marchuk, Y. (1997) Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl Acad. Sci. USA, 94, 14602-14607.
30. Kwan, K.M. (2002) Conditional alleles in mice: Practical considerations for tissue-specific knockouts. Genesis, 32, 49-62.
31. Lewandoski, M. (2001) Conditional control of gene expression in the mouse. Nat. Rev. Genet., 2, 743-755.
32. Shehee, W.R., Oliver, P. and Smithies, O. (1993) Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene. Proc. Natl Acad., Sci. USA, 90, 3177-3181.
33. Matsuda R., Nishikawa, A. and Tanaka, H. (1995) Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. (Tokyo), 118, 959-964.
34. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol., 139, 375-385.
35. Bruning, J.C., Michael, M.D., Winnay, J.N., Hayashi, T., Horsch, D., Accili, D., Goodyear, L.J. and Kahn, C.R. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell, 2, 559-569.
36. Wang, J., Wilhelmsson, H., Graff, C., Li, H., Oldfors, A., Rustin, P., Bruning, J.C., Kahn C.R., Clayton, D.A., Barsh, G.S. et al. (1999) Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat. Genet., 21, 133-137.
37. Allamand, V., Donahue, K.M., Straub, V., Davisson, R.L., Davidson, B.L. and Campbell, K.P. (2000) Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice. Gene Ther., 7, 1385-1391.
38. Bushby, K.M. (1999) Making sense of the limb-girdle muscular dystrophies. Brain, 122, 1403-1420.
39. Roberds, S.L. and Campbell, K.P. (1995) Adhalin mRNA and cDNA sequence are normal in the cardiomyopathic hamster. FEBS Lett., 364, 245-249.
40. Bueno, M.R., Moreira, E.S., Vainzof, M., Chamberlain, J., Marie, S.K., Pereira, L., Akiyama, J., Roberds, S.L., Campbell, K.P. and Zatz, M. (1995) A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy. Hum. Mol. Genet., 4, 1163-1167.
41. Hackman, P., Juvonen, V., Sarparanta, J., Penttinen, M., Aarimaa, T., Uusitalo, M., Auranen, M., Pihko, H., Alen, R., Junes, M. et al. (2005) Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients. Muscle Nerve, 31, 199-204.
42. Angelini, C., Fanin, M., Menegazzo, E., Freda, M.P., Duggan, D.J. and Hoffman, E.P. (1998) Homozygous alpha-sarcoglycan mutation in two siblings: One asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient. Muscle Nerve, 21, 769-775.
43. Duggan, D.J., Fanin, M., Pegoraro, E., Angelini, C. and Hoffman, E.P. (1996) alpha-Sarcoglycan (adhalin) deficiency: Complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations. J. Neurol. Sci., 140, 30-39.
44. Duggan, D.J., Gorospe, J.R., Fanin, M., Hoffman, E.P. and Angelini, C. (1997) Mutations in the sarcoglycan genes in patients with myopathy. N. Engl. J. Med., 336, 618-624.
45. Bross, P., Corydon, T.J., Andresen, B.S., Jorgensen, M.M., Bolund, L. and Gregersen, N. (1999) Protein misfolding and degradation in genetic diseases. Hum. Mutat., 14, 186-198.
46. Erickson, R.R., Dunning, L.M. and Holtzman, J.L. (2006) The effect of aging on the chaperone concentrations in the hepatic, endoplasmic reticulum of male rats: The possible role of protein misfolding due to the loss of chaperones in the decline in physiological function seen with age. J. Gerontol. A. Biol. Sci. Med. Sci., 61, 435-443.
47. Choi, B.H. and Kim, J.S. (2004) Age-related decline in expression of calnexin. Exp. Mol. Med., 36, 499-503.
48. Beckmann, J.S., Brown, R.H., Muntoni, F., Urtizberea, A., Bonnemann, C. and Bushby, K.M. (1999) 66th/67th ENMC sponsored international workshop: The limb-girdle muscular dystrophies, 26-28 March 1999, Naarden, The Netherlands. Neuromuscul. Disord., 9, 436-445.
49. Bartoli, M., Gicquel, E., Barrault, L., Soheili, T., Malissen, M., Malissen, B., Vincent-Lacaze, N., Perez, N., Udd, B., Danos, O. et al. (2008) Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation. Hum. Mol. Genet., doi:10.1093/hmg/ddn0029.
50. Fougerousse, F., Bartoli, M., Poupiot, J., Arandel, L., Durand, M., Guerchet, N., Gicquel, E., Danos, O. and Richard, I. (2007) Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector. Mol. Ther., 15, 53-61.
51. Li, X., Eastman, E.M., Schwartz, R.J. and Draghia-Akli, R. (1999) Synthetic muscle promoters: Activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol., 17, 241-245.
52. Lee, A.H., Suh, Y.S., Sung, J.H., Yang, S.H. and Sung, Y.C. (1997) Comparison of various expression plasmids for the induction of immune response by DNA immunization. Mol. Cells, 7, 495-501.
53. Chen, P., Tian, J., Kovesdi, I. and Bruder, J.T. (2008) Promoters influence the kinetics of transgene expression following adenovector gene delivery. J. Gene Med., 10, 123-131.
54. Roberds, S.L., Anderson, R.D., Ibraghimov-Beskrovnaya, O. and Campbell, K.P. (1993) Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). J. Biol. Chem. 268, 23739-23742.
55. Durbeej, M. and Campbell, K.P. (1999) Biochemical characterization of the epithelial dystroglycan complex. J. Biol. Chem., 274, 26609-26616.
56. Cormack, B. (1997) Mutagenesis of cloned DNA. In Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (eds), Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York NY, pp. 8.5.7-8.5.9.
57. Ohlendieck, K., Ervasti, J.M., Snook, J.B. and Campbell, K.P. (1991) Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J. Cell Biol., 112, 135-148.
58. Percy, M.E., Chang, L.S., Murphy, E.G., Oss, I., Verellen-Dumoulin, C. and Thompson, M.W. (1979) Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle Nerve, 2 329-339.